INFLAMASE FORTE Rx
Generic Name and Formulations:
Prednisolone sodium phosphate 1%; oph soln; contains benzalkonium chloride.
Indications for INFLAMASE FORTE:
Initially 1–2 drops every hour during day and every 2 hours at night; after response, reduce to 1 drop every 4 hours; then 1 drop 3–4 times daily as needed.
Ocular fungal, mycobacterial, viral (except herpes zoster), or untreated bacterial infections.
Not for use after uncomplicated removal of foreign body. Corneal or scleral thinning. Glaucoma. Monitor IOP and for secondary infections. Avoid abrupt cessation in prolonged use. Pregnancy (Cat.C). Nursing mothers.
Prolonged use: increased IOP, cataracts, corneal perforations, optic nerve damage, delayed wound healing; may mask or worsen infections.
Soln—5mL, 10mL, 15mL
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Breast Implant-Associated Anaplastic Large Cell Lymphoma — In the Clinic
- Immune Checkpoint Inhibitors for NSCLC: Current and Future Approaches
- Can A Consortium of Hospitals Help To Reduce Drug Prices?
- Clostridium Difficile Infection in Patients With Cancer — In the Clinic
- 5α-Reductase Inhibitors Do Not Increase Risk of High-Grade Prostate Cancer
- FDA Approves Front-Line Brentuximab Vedotin Plus Chemotherapy for Hodgkin Lymphoma
- NSCLC: Pretreatment Weight Loss May Be Linked to Socioeconomic Status
- Targeted and Immunotherapies for Metastatic Renal Cell Carcinoma
- Atezolizumab, Carboplatin, Nab-Paclitaxel Combination Prolongs PFS in NSCLC
- Model May Identify Patients With Gastric Cancer Likely To Benefit From Chemotherapy